- Home
- BMI vs SRRK Comparison
BMI vs SRRK Comparison
Compare BMI & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMI | SRRK |
|---|---|---|
| Founded | 1905 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.9B |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BMI | SRRK |
|---|---|---|
| Price | $156.09 | $44.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $193.14 | $51.20 |
| AVG Volume (30 Days) | 491.9K | ★ 757.3K |
| Earning Date | 04-29-2026 | 04-10-2026 |
| Dividend Yield | ★ 1.03% | N/A |
| EPS Growth | ★ 13.24 | N/A |
| EPS | ★ 4.79 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.50 | N/A |
| Revenue Next Year | $6.84 | $21,831.23 |
| P/E Ratio | $32.52 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $139.14 | $22.71 |
| 52 Week High | $256.08 | $49.82 |
Technical Indicators
Market Signals| Indicator | BMI | SRRK |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 44.17 |
| Support Level | $139.14 | $42.74 |
| Resistance Level | $184.62 | $48.79 |
| Average True Range (ATR) | 5.40 | 1.76 |
| MACD | 1.10 | -0.25 |
| Stochastic Oscillator | 62.24 | 8.71 |
Price Performance
Historical ComparisonAbout BMI Badger Meter Inc.
Badger Meter is a provider of water management solutions. The company's solutions encompass measurement and control hardware, connectivity and communication, data visualization and software. Badger Meter has global operations, with the vast majority of revenue derived from the US.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.